Illustrative image – not actual.Elder Pharmaceuticals is planning to acquire three small Bulgarian pharma companies through its wholly-owned subsidiary Elder-Biomeda through a share swap deal. All the three companies are sister concerns of Biomeda.
In August 2008, Elder entered into an agreement to buy 51 per cent stake in Biomeda for Euro 5 million. Currently, Elder is planning to increase that stake to 61 per cent. The promoters of the three companies in return will hold the remaining 39 per cent in Biomeda. The company will use these companies to introduce its products in Europe and other international markets.
